Clinical Trials Browser

Suspended × trastuzumab deruxtecan × Tumor-Agnostic × Clear all

NCT05372614 2026-03-19

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Phase 1 Suspended

Neoplasm Metastasis